Press Releases & Healthcare News

December 05, 2023
OGSIVEO (nirogacestat) FDA Approved for Desmoid Tumors, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, McKesson Plasma & Biologics, Providers, Pharmaceutical Distribution, Manufacturers
December 01, 2023
TRUQAP (capivasertib), FDA Approved for the Treatment of Breast Cancer, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, McKesson U.S. Pharmaceutical, Providers, Pharmaceutical Distribution, Manufacturers
November 15, 2023
FRUZAQLA (fruquintinib), FDA Approved for the Treatment of Metastatic Colorectal Cancer, Available at Biologics by McKesson
Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Solutions & Services, Pharmaceutical Distribution, Manufacturers
November 13, 2023
The US Oncology Network Extends Its Reach into Tennessee with The Addition of Nashville Oncology Associates
Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, Consumers, US Oncology
November 01, 2023
McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance
Keywords: Corporate, Earnings, Investors, Corporate
October 26, 2023
McKesson Corporation Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
October 11, 2023
FDA Selects Ontada to Investigate the Natural History of Rare Cancers Treated in the U.S. Community Oncology Setting
Keywords: Ontada, Ontada, Pharmaceutical Solutions & Services, Electronic Health Records, Manufacturers
September 27, 2023
McKesson Corporation Announces Second Quarter Fiscal 2024 Earnings Release Date
Keywords: Corporate, Earnings, Investors, Corporate
September 25, 2023
Ontada Names Christine Davis Its New President
Keywords: Ontada, Ontada, Pharmaceutical Solutions & Services, Providers, Electronic Health Records, Manufacturers, Corporate
September 20, 2023
OJJAARA (momelotinib), FDA Approved for the Treatment of Myelofibrosis in Adults with Anemia, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems
August 16, 2023
Genpact Extends Relationship to Transform McKesson’s Finance Operations for Enhanced Service and Competitive Growth
Keywords: Corporate, Investors, Corporate
August 04, 2023
McKesson Medical-Surgical Supports National Health Center Week 2023
Keywords: McKesson Medical-Surgical, Consumers, Community Days, Manufacturers, McKesson Medical-Surgical
August 04, 2023
VANFLYTA (quizartinib), FDA Approved in the U.S. for Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, McKesson U.S. Pharmaceutical, Providers, Pharmaceutical Distribution, Manufacturers
August 02, 2023
McKesson Corporation Reports Fiscal 2024 First-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
July 24, 2023
McKesson Raises Quarterly Dividend by 15% to $0.62 Per Share
Keywords: Corporate, Earnings, Investors, Corporate
July 10, 2023
Cancer Center of Kansas Joins The US Oncology Network
Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, Consumers, US Oncology
June 28, 2023
McKesson Corporation Announces First-Quarter Fiscal 2024 Earnings Release Date
Keywords: Corporate, Earnings, Investors, Corporate
June 27, 2023
McKesson ideaShare Recognizes Excellence in Community Pharmacy
Keywords: PSS-Health Mart, Corporate, Health Mart, Health Mart, Pharmacies, Corporate
June 22, 2023
McKesson Unveils New Private Brand of Over-the-Counter Pharmacy Products
Keywords: Pharmaceutical Solutions & Services, Corporate, Health Mart, Consumers, Health Mart, Pharmaceutical Distribution, Pharmacies, Healthcare Providers, Corporate
June 15, 2023
McKesson Ventures’ Dave Schulte Named One of Healthcares Top 25 Investors
Keywords: Corporate, McKesson Ventures, Investors, Corporate
June 14, 2023
McKesson Releases Impact Report
Keywords: Corporate, Investors, Corporate
June 13, 2023
McKesson Corporation Announces the Expiration and Results of Tender Offer for Any and All 3.796% Notes Due 2024
Keywords: Corporate, Investors, Corporate
June 13, 2023
McKesson Corporation Announces Pricing Terms of Tender Offer for Any and All 3.796% Notes Due 2024
Keywords: Corporate, Investors, Corporate
June 07, 2023
McKesson Corporation Commences Tender Offer for Any and All 3.796% Notes Due 2024
Keywords: Corporate, Corporate
June 05, 2023
Research Presented at ASCO 2023 Shows Implementing Value-Based Care Strategies Such as Dose Rounding Reduces Drug Waste and Total Cost of Care
Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology
June 04, 2023
Research Results from Ontada HOPE Studies Presented at ASCO 2023 Illuminate How Social Determinants of Health Impact Different Patient Populations with Triple-Negative Breast Cancer
Keywords: Ontada, Ontada, Pharmaceutical Solutions & Services, Providers, Electronic Health Records, Manufacturers, McKesson Pharmacy Systems
May 08, 2023
McKesson Corporation Reports Fiscal Fourth-Quarter and Full-year Results and Raises Long-Term Segment Growth Targets
Keywords: Corporate, Earnings, Investors, Corporate
May 05, 2023
Research to Be Presented at ISPOR 2023 Illuminates the Economic Costs of Melanoma and Non-Small Cell Lung Cancer and Provides Insights That Can Help Strengthen the Quality and Approach to Real-World Evidence Generation
Keywords: Ontada, Ontada, Pharmaceutical Solutions & Services, Providers, Electronic Health Records, Manufacturers, McKesson Pharmacy Systems
April 27, 2023
McKesson Corporation Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
April 06, 2023
Regional Cancer Care Associates Joins The US Oncology Network
Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, Consumers, US Oncology
April 05, 2023
Biologics by McKesson Named the Exclusive Pharmacy for FDA- Approved SKYCLARYS (omaveloxolone) for the Treatment of Friedreich's Ataxia
Keywords: Pharmaceutical Solutions & Services, McKesson U.S. Pharmaceutical, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems
April 05, 2023
McKesson ideaShare Invites Independent Community Pharmacy Teams to Annual Industry Education and Networking Event
Keywords: PSS-Retail Pharmacy, Corporate, Health Mart, Pharmacies, McKesson Pharmacy Systems, Corporate
March 27, 2023
McKesson Corporation Announces Fourth-Quarter Fiscal 2023 Earnings Release Date
Keywords: Corporate, Earnings, Investors, Corporate
March 20, 2023
McKesson Medical-Surgical Government Solutions Awarded Federal Supply Schedule Medical Equipment and Supply Contract
Keywords: McKesson Medical-Surgical, Chronic Care Management, Providers, Disease Management, Pharmaceutical Distribution, Manufacturers, McKesson Medical-Surgical
February 15, 2023
McKesson Designated by CMS as 2023 Qualified Clinical Data Registry
Keywords: Ontada, Ontada, Pharmaceutical Solutions & Services, Providers, Electronic Health Records, US Oncology, McKesson Pharmacy Systems
February 14, 2023
JAYPIRCA (pirtobrutinib), FDA Approved for Treatment of Relapsed or Refractory Mantle Cell Lymphoma, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, McKesson U.S. Pharmaceutical, Providers, Pharmaceutical Distribution, Manufacturers
February 10, 2023
ORSERDU (elacestrant), FDA Approved for ER+/HER2- Advanced or Metastatic Breast Cancer, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, McKesson Plasma & Biologics, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems
February 01, 2023
McKesson Corporation Reports Fiscal 2023 Third-Quarter Results and Raises Full-Year Guidance
Keywords: Corporate, Earnings, Investors, Corporate
January 26, 2023
McKesson Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
January 23, 2023
McKesson Receives Approval of Its Near-term Climate Change Targets by the Globally Recognized Science Based Targets initiative
Keywords: COVID-19, Corporate, Chronic Care Management, McKesson Ventures, Providers, Consumers, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate
January 17, 2023
The US Oncology Network Continues its Rapid Growth into New Communities, Adding Epic Care and Nexus Health
Keywords: US Oncology Network, Pharmaceutical Solutions & Services, Providers, Consumers, US Oncology, Healthcare Providers
December 28, 2022
McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date
Keywords: Corporate, Earnings, Investors, Corporate
December 22, 2022
FYARRO (sirolimus protein-bound particles for injectable suspension) (albumin-bound), FDA Approved for Treatment of Locally Advanced Unresectable or Metastatic Malignant Perivascular Epithelioid Cell Tumor, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems
December 19, 2022
REZLIDHIA (olutasidenib), FDA-Approved for Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems
December 14, 2022
KRAZATI® (adagrasib), FDA Approved for Treatment of Advanced Non-Small Cell Lung Cancer Harboring the KRASG12C Mutation, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems
December 12, 2022
ELAHERE™ (mirvetuximab soravtansine-gynx), FDA Approved for Platinum-Resistant Ovarian Cancer, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, McKesson Plasma & Biologics, Providers, Pharmaceutical Distribution, Pharmacies
November 07, 2022
McKesson Foundation Awards $4.1 Million to Pharmacy Schools to Help Close Diversity Gap and Improve Health Outcomes
Keywords: Corporate, Providers, Consumers, Health Mart, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate
November 01, 2022
McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance
Keywords: Corporate, Earnings, Investors, Corporate
October 27, 2022
McKesson Corporation Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
October 26, 2022
McKesson Opens Its Most Technologically Advanced Healthcare Distribution Center in Jeffersonville, Ohio
Keywords: PSS-Retail Pharmacy, Consumers, Pharmaceutical Distribution, Pharmacies, Manufacturers, Investors, Healthcare Providers, Corporate
October 18, 2022
McKesson Thought Leaders Are Key Presenters at 2022 Association for Value-Based Cancer Care Summit
Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology
September 29, 2022
McKesson Corporation Extends Pharmaceutical Distribution Agreement with CVS Health
Keywords: Corporate, Earnings, Investors, Corporate
September 19, 2022
McKesson Signs Agreement to Acquire Rx Savings Solutions
Keywords: Corporate, Chronic Care Management, Providers, Consumers, Disease Management, Electronic Prescribing, Pharmaceutical Distribution, Pharmacies, Investors, Healthcare Providers, Corporate
September 13, 2022
McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer
Keywords: COVID-19, Corporate, Chronic Care Management, McKesson Ventures, Providers, Consumers, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate
August 04, 2022
McKesson Medical-Surgical Supports National Health Center Week 2022
Keywords: McKesson Medical-Surgical, Providers, Consumers, Community Days, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, McKesson Medical-Surgical
August 03, 2022
McKesson Corporation Reports Fiscal 2023 First-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
July 25, 2022
McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share
Keywords: Corporate, Earnings, Investors, Corporate
July 25, 2022
Biologics by McKesson is now the Exclusive Specialty Pharmacy Provider of XERMELO (telotristat ethyl), an FDA Approved Therapy for Carcinoid Syndrome Diarrhea
Keywords: Pharmaceutical Solutions & Services, Pharmaceutical Distribution, Pharmacies, McKesson Pharmacy Systems
July 20, 2022
McKesson Earns Top Score as One of the Best Places to Work for Disability Inclusion
Keywords: Corporate, Chronic Care Management, McKesson Ventures, Providers, Consumers, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate
July 12, 2022
McKesson ideaShare Conference Draws Attendees From More Than 2,100 Independent Pharmacies to First In-Person Conference Since 2019
Keywords: Pharmaceutical Solutions & Services, McKesson Pharmacy Systems, Health Mart, Pharmacies, McKesson Pharmacy Systems
June 29, 2022
McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date
Keywords: Corporate, Earnings, Investors, Corporate
June 23, 2022
McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research
Keywords: US Oncology Network, PSS-The US Oncology Network, Corporate, Providers, Disease Management, US Oncology, Nurses, Healthcare Providers, Corporate
June 06, 2022
New MYLUNG Consortium Research Demonstrates Remote Pharmacist Intervention Significantly Increases Clinical Trial Enrollments in Community Oncology Setting
Keywords: US Oncology Network, Ontada, PSS-The US Oncology Network, US Oncology, Pharmacies, Manufacturers
June 03, 2022
Investigators from US Oncology Research, The US Oncology Network and Ontada Present Data Highlighting Key Advances and Insights at the 2022 American Society of Clinical Oncology Annual Meeting
Keywords: US Oncology Network, Ontada, PSS-The US Oncology Network, US Oncology, Pharmacies, Manufacturers, Healthcare Providers
May 05, 2022
McKesson Reports Fiscal 2022 Fourth Quarter and Full-Year Results
Keywords: Corporate, Earnings, Investors, Corporate
May 03, 2022
Distributors Agree to Opioid Settlement with Washington State
Keywords: Corporate, Investors, Corporate
April 28, 2022
McKesson Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
April 07, 2022
McKesson Corporation Completes Divestiture of UK Businesses, Announces Fourth Quarter Fiscal 2022 Earnings Release Date
Keywords: Corporate, Earnings, Investors, Corporate
April 01, 2022
McKesson’s Board of Directors Elects W. Roy Dunbar as New Director
Keywords: Corporate, Chronic Care Management, McKesson Ventures, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Investors, Corporate
March 14, 2022
McKesson Supports Ukraine Relief Efforts
Keywords: Corporate, Corporate
March 14, 2022
VONJO (pacritinib), FDA Approved for Treatment of Intermediate or High-risk Myelofibrosis, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems
March 02, 2022
PYRUKYND (mitapivat), FDA Approved for Treatment of Hemolytic Anemia in Adults with Pyruvate Kinase Deficiency, Available Exclusively at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems
February 25, 2022
Distributors Approve Opioid Settlement Agreement
Keywords: Corporate, Pharmaceutical Distribution, Manufacturers, Investors, Corporate
February 08, 2022
McKesson Designated by CMS as 2022 Qualified Clinical Data Registry
Keywords: US Oncology Network, Ontada, Ontada, PSS-The US Oncology Network, Corporate, Providers, US Oncology, Healthcare Providers, Corporate
February 07, 2022
Ontada Names Dr. Nicholas Robert as Chief Medical Officer
Keywords: Ontada, Ontada
February 02, 2022
McKesson Reports Fiscal 2022 Third Quarter-Results
Keywords: Corporate, Earnings, Investors, Corporate
January 27, 2022
McKesson Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
January 27, 2022
McKesson Recognized as one of the “Best Places to Work for LGBTQ+ Equality” for Ninth Year in a Row
Keywords: Corporate, Chronic Care Management, McKesson Ventures, Consumers, Community Days, Electronic Health Records, M&A, Earnings, Disease Management, Picture Archive Communications System, Health Mart, Electronic Prescribing, Computerized Physician Order Entry, Revenue Cycle Management, Patient Safety, US Oncology, Pharmaceutical Distribution, Corporate
January 25, 2022
Ontada Names Viraj Narayanan as Chief Commercial Officer
Keywords: Ontada, Ontada
January 18, 2022
McKesson’s Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors
Keywords: Corporate, Corporate
December 29, 2021
McKesson Corporation Announces Third Quarter Fiscal 2022 Earnings Release Date and Participation in January Conference
Keywords: Corporate, Earnings, Investors, Corporate
December 22, 2021
Distributors Announce Extension of Opioid Settlement Sign-On Period, Participation of New Mexico
Keywords: Corporate, Corporate
December 22, 2021
TARPEYO^TM (budesonide) delayed release capsules, FDA Approved to Reduce Proteinuria in IgA Nephropathy, Available Exclusively at Biologics by McKesson
Keywords: PSS-McKesson Plasma & Biologics, McKesson Plasma & Biologics, Providers, Pharmaceutical Distribution, Manufacturers
December 20, 2021
McKesson Corporation Enters Agreement to Sell its Austrian Business to Quadrifolia Management GmbH
Keywords: Corporate, Investors, Corporate
December 09, 2021
US Oncology Research, The US Oncology Network and Ontada Announce Data Presentations across Areas of Critical Need at 2021 American Society of Hematology Annual Meeting and Exposition
Keywords: Pharmaceutical Solutions & Services, Providers, US Oncology, Manufacturers, McKesson Pharmacy Systems
December 08, 2021
McKesson Investor Day to Highlight Progress Against Growth Strategies and Long-Term Financial Targets
Keywords: Corporate, Earnings, Corporate
December 06, 2021
BESREMi (ropeginterferon alfa-2b-njft), FDA Approved for Treatment of Polycythemia Vera, Available at Biologics by McKesson
Keywords: Corporate, Providers, Pharmaceutical Distribution, Pharmacies, Manufacturers, Corporate
December 03, 2021
Newly Approved LIVTENCITY (maribavir) Now Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, Providers, Pharmaceutical Distribution, Manufacturers, McKesson Pharmacy Systems
December 01, 2021
McKesson to Host Investor Day on December 8, 2021
Keywords: Corporate, Earnings, Investors, Corporate
November 30, 2021
Walgreens Boots Alliance Acquires Remaining Stake in German GEHE-Alliance Healthcare Joint Venture From McKesson
Keywords: Corporate, Investors, Corporate
November 16, 2021
New Metrics Show The US Oncology Network Practices Leading the Way in Value-Based Care
Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology
November 04, 2021
McKesson Opens State-of-the-Art Distribution Center in Michigan
Keywords: Corporate, McKesson U.S. Pharmaceutical, Providers, Consumers, Pharmaceutical Distribution, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate
November 03, 2021
Ontada Names Sagran Moodley as Chief Innovation and Technology Officer
Keywords: Ontada, Ontada
November 03, 2021
EXKIVITY (mobocertinib), First and Only FDA Approved Oral Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer, Available at Biologics by McKesson
Keywords: Pharmaceutical Solutions & Services, Corporate, Pharmaceutical Distribution, Pharmacies, Manufacturers, McKesson Pharmacy Systems, Corporate
November 01, 2021
McKesson Reports Fiscal 2022 Second-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
November 01, 2021
McKesson Corporation Enters Agreement to Sell UK Businesses to AURELIUS
Keywords: Corporate, Corporate
October 28, 2021
McKesson Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
October 20, 2021
Health Mart Unveils Digital Portfolio for Community Pharmacies
Keywords: PSS-Health Mart, Health Mart, Consumers, Health Mart, Pharmacies
September 28, 2021
Distributors Announce Settlement with Cherokee Nation
Keywords: Corporate, Corporate
September 27, 2021
McKesson Corporation to Announce Second Quarter Fiscal 2022 Results on November 1, 2021
Keywords: Corporate, Earnings, Investors, Corporate
September 20, 2021
Hayat Pharmacy Named Health Mart Pharmacy of the Year
Keywords: PSS-Health Mart, Health Mart, Health Mart
September 20, 2021
The US Oncology Network Announces Trusted Leader Jason Hammonds as New President
Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology
September 16, 2021
McKesson Launches Rapid Returns Solution for Health Systems
Keywords: Corporate, Pharmacies, Healthcare Providers, Corporate
September 15, 2021
Ontada Launches HOPE Studies, Empowering Oncologists to Leverage Real-World Data and Address Healthcare Disparities
Keywords: Ontada, Ontada, Corporate, US Oncology
September 07, 2021
McKesson’s Board of Directors Elects Dr. Richard H. Carmona as New Independent Director
Keywords: Corporate, Corporate
September 04, 2021
Distributors Announce Proposed Opioid Settlement Will Proceed to Next Phase
Keywords: Corporate, Corporate
August 26, 2021
Ontada Signs Strategic Agreement with Merck to Facilitate the Development of Data-Driven Insights to Impact Quality of Cancer Care
Keywords: Ontada, Ontada, Corporate, Corporate
August 24, 2021
McKesson ideaShare to Bring Together 2,000 Community Pharmacies Virtually
Keywords: Corporate, Health Mart, Health Mart, Pharmacies, Corporate
August 20, 2021
WELIREGTM (belzutifan), FDA Approved, Available at Biologics by McKesson
Keywords: Corporate, Chronic Care Management, Providers, Manufacturers, Corporate
August 16, 2021
McKesson to Host Investor Day on December 8, 2021
Keywords: Corporate, Investors, Corporate
August 04, 2021
McKesson Reports Fiscal 2022 First-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
July 30, 2021
REZUROCK (belumosudil) tablets, FDA Approved for Treatment of Chronic Graft-Versus-Host Disease, Available at Biologics by McKesson
Keywords: Corporate, Pharmaceutical Distribution, Manufacturers, Corporate
July 26, 2021
McKesson Raises Quarterly Dividend by 12% to $0.47 Per Share
Keywords: Corporate, Earnings, Investors, Corporate
July 22, 2021
McKesson Corporation Announces Pricing and Upsizing of Tender Offer
Keywords: Corporate, Investors, Corporate
July 22, 2021
McKesson Corporation Announces Early Tender Results and Intention to Increase the Tender Cap
Keywords: Corporate, Earnings, Investors, Corporate
July 21, 2021
Distributors Announce Proposed Opioid Settlement Agreement
Keywords: Corporate, Corporate
July 20, 2021
Distributors Reach Opioid Settlement with New York State
Keywords: Corporate
July 13, 2021
McKesson Named One of the Best Places to Work for Disability Inclusion
Keywords: Corporate, Corporate
July 08, 2021
McKesson Corporation Announces Offer to Purchase $500 Million Aggregate Principal Amount of Debt
Keywords: Corporate, Corporate
July 07, 2021
McKesson Corporation Enters Agreement to Sell Certain European Businesses to the PHOENIX Group
Keywords: Corporate, Corporate
June 30, 2021
McKesson Corporation to Announce First Quarter Fiscal 2022 Results on August 4, 2021
Keywords: Corporate, Earnings, Investors, Corporate
June 21, 2021
TRUSELTIQ (infigratinib), FDA Approved for Treatment of Cholangiocarcinoma, Available at Biologics by McKesson
Keywords: Corporate, Disease Management, Corporate
June 11, 2021
LUMAKRAS (sotorasib), FDA Approved for Treatment of KRAS G12C-mutated Locally Advanced or Metastatic Non-small Cell Lung Cancer, Available at Biologics by McKesson
Keywords: Corporate, Disease Management, Corporate
June 04, 2021
First Phase Results of MYLUNG Consortium Provide Historical View of Biomarker Testing Patterns and Identify Data Gaps for Ongoing Prospective Research
Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology
June 03, 2021
US Oncology Research, The US Oncology Network and Ontada Announce Clinical Data Showcased in Plenary and Oral Sessions at ASCO Annual Meeting
Keywords: US Oncology Network, PSS-The US Oncology Network, Corporate, US Oncology, Corporate
May 19, 2021
Community Pharmacies with Health Mart, Health Mart Atlas Administer 1 Million COVID-19 Vaccine Doses
Keywords: COVID-19, PSS-Health Mart, Corporate, Health Mart, Providers, Health Mart, Pharmacies, Healthcare Providers
May 06, 2021
McKesson Reports Fiscal 2021 Fourth-Quarter Results and Full-Year Results
Keywords: Corporate, Earnings, Investors, Corporate
May 05, 2021
McKesson Commits to Set Science-Based Targets to Reduce Greenhouse Gas Emissions
Keywords: Corporate, Corporate
April 29, 2021
McKesson Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors
April 19, 2021
McKesson Announces N. Anthony Coles, M.D. Will Not Stand for Re-Election to McKesson Board of Directors
Keywords: Corporate, Corporate
April 19, 2021
NULIBRY (fosdenopterin), First and Only FDA-Approved Therapy to Reduce the Risk of Mortality in Patients with Molybdenum Cofactor Deficiency Type A, Available Exclusively at Biologics by McKesson
Keywords: Corporate, Disease Management, Pharmaceutical Distribution, Pharmacies, Corporate
April 01, 2021
McKesson Corporation to Announce Fourth Quarter Fiscal 2021 Results on May 6, 2021
Keywords: Corporate, Earnings, Investors, Corporate
April 01, 2021
The US Oncology Network continues its rapid growth and enhances surgical expertise with addition of physicians from Texas Colon & Rectal Specialists as a part of Texas Oncology
Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology
March 25, 2021
McKesson Approved as QCDR for 2021 MIPS Program Year
Keywords: US Oncology Network, Ontada, Ontada, PSS-The US Oncology Network, Corporate, US Oncology, Corporate
March 22, 2021
Ontada Appoints Susan Shiff, Ph.D., MBA, as President
Keywords: Ontada, Ontada, Corporate, Corporate
March 18, 2021
McKesson launches ScriptPAS, empowering oncology practices to reduce time to therapy while enhancing patient care
Keywords: Corporate, Providers, Corporate
March 16, 2021
McKesson Expands Integrated Pharmacy Services for Specialty Clinics
Keywords: Corporate, Pharmacies, Corporate
March 12, 2021
FOTIVDA (tivozanib), FDA Approved for Treatment of Relapsed/Refractory Advanced Renal Cell Carcinoma, Available at Biologics by McKesson
Keywords: Corporate, Providers, Pharmacies, Corporate
March 01, 2021
McKesson Begins Distributing the Johnson & Johnson COVID-19 Vaccine
Keywords: COVID-19, Corporate, Providers, Consumers, Pharmacies, Manufacturers, Corporate
February 18, 2021
Ontada’s Clear Value Plus Provides 800,000th Chemotherapy Treatment Decision
Keywords: US Oncology Network, Corporate, Corporate
February 11, 2021
McKesson RxOwnership Expands Commitment to Pharmacy Owners
Keywords: Corporate, Corporate
February 04, 2021
MYLUNG Study Launches, Aiming to Advance Use of Precision Medicine for Metastatic Non-Small Cell Lung Cancer Patients
Keywords: Corporate, Providers, US Oncology, Corporate
February 02, 2021
McKesson Reports Fiscal 2021 Third-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
January 28, 2021
McKesson Recognized as one of the “Best Places to Work for LGBTQ Equality” for Eighth Year in a Row
Keywords: Corporate, Corporate
January 28, 2021
McKesson Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
January 21, 2021
ORGOVYX (relugolix), the First FDA-Approved Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer, Available at Biologics by McKesson
Keywords: Corporate, Corporate
January 15, 2021
McKesson Statement on Political Contributions
Keywords: Corporate, Corporate
December 28, 2020
McKesson Corporation Announces Third Quarter Fiscal 2021 Earnings Release Date and Participation in January Conferences
Keywords: Corporate, Earnings, Investors, Corporate
December 20, 2020
McKesson Fills Initial Government Orders for Moderna’s COVID-19 Vaccine
Keywords: COVID-19, Corporate, Corporate
December 16, 2020
McKesson and TailorMed Collaborate to Reduce Patient Financial Barriers to Care
Keywords: Corporate, Corporate
December 04, 2020
Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in Communities
Keywords: Corporate, Corporate
December 03, 2020
McKesson Launches Ontada, an Oncology Technology and Insights Business Dedicated to Help Advance Cancer Research and Care
Keywords: Corporate, Corporate
December 02, 2020
US Oncology Research Announces Schedule of Presentations at the Virtual 2020 American Society of Hematology Annual Meeting and Exposition
Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology
November 19, 2020
McKesson Appoints Dr. Kelvin A. Baggett to Chief Impact Officer
Keywords: Corporate, Corporate
November 11, 2020
The US Oncology Network Enrolls 100,000th Patient in the Oncology Care Model, Enhancing Care While Saving Medicare over $100 Million
Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology
November 10, 2020
McKesson Joins United Nations Global Compact Initiative
Keywords: Corporate, Corporate
November 03, 2020
McKesson Reports Fiscal 2021 Second-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
November 02, 2020
Walgreens Boots Alliance and McKesson Complete the Formation of German Wholesale Joint Venture
Keywords: Corporate, Corporate
October 29, 2020
McKesson Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
October 27, 2020
Providing Care in a Pandemic and Beyond: Three Considerations for Hospital Leaders
Keywords: Corporate, Corporate
October 22, 2020
The US Oncology Network continues to grow, enhancing community cancer care by welcoming two more practices
Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology
October 19, 2020
McKesson’s Board of Directors Elects Linda Mantia as New Independent Director
Keywords: Corporate, Corporate
October 06, 2020
Dr. Robert L. Coleman Named an OncLive Giant of Cancer Care
Keywords: US Oncology Network, PSS-The US Oncology Network, Corporate, US Oncology
October 05, 2020
McKesson Corporation to Announce Second Quarter Fiscal 2021 Results on November 3, 2020
Keywords: Corporate, Earnings, Investors, Corporate
September 30, 2020
Elevation Oncology and US Oncology Research Announce Collaboration to Expand Genomic Testing of Solid Tumors and Local Site Activation in Support of the Phase 2 CRESTONE Study
Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology
September 29, 2020
US Oncology Research Achieves Milestone of over 100 FDA-Approved Cancer Therapies
Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology
September 23, 2020
ValuCare Center Named Health Mart Pharmacy of the Year
Keywords: Corporate, Health Mart, Corporate
September 17, 2020
Health Mart Pharmacies Fight Flu to Protect Patients
Keywords: Corporate, Health Mart, Corporate
September 17, 2020
GAVRETO (pralsetinib), FDA Approved for Treatment of Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer, Available at Biologics by McKesson
Keywords: Corporate, Corporate
September 16, 2020
McKesson Ventures Grows Leadership Team with New Partner Promotions
Keywords: Corporate, McKesson Ventures, Corporate
September 02, 2020
Health Mart Receives Pharmacy Technician Training Program Accreditation
Keywords: PSS-Health Mart, Health Mart, Health Mart, Pharmacies
August 24, 2020
INQOVI (decitabine and cedazuridine) Tablets, FDA Approved for Treatment of Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia, Available at Biologics by McKesson
Keywords: Corporate, Corporate
August 18, 2020
McKesson Named to the Diversity Best Practices Inclusion Index
Keywords: Corporate, Corporate
August 14, 2020
McKesson to Distribute Future COVID-19 Vaccines in Support of Operation Warp Speed
Keywords: Corporate, Corporate
August 10, 2020
McKesson Canada names Rebecca McKillican Chief Executive Officer
Keywords: Corporate, Corporate
August 10, 2020
Supplylogix to Help Pharmacy Customers Track Inventory Movement with Pinpoint Order Update
Keywords: Corporate, Corporate
August 04, 2020
The US Oncology Network Names Vivek Kavadi, MD, Chief Radiation Oncologist
Keywords: US Oncology Network, PSS-The US Oncology Network, Providers, US Oncology
August 03, 2020
McKesson Reports Fiscal 2021 First-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
July 29, 2020
McKesson Declares Quarterly Dividend July 29, 2020
Keywords: Corporate, Earnings, Investors, Corporate
July 16, 2020
McKesson Named One of the Best Places to Work for Disability Inclusion
Keywords: Corporate, Corporate
July 06, 2020
McKesson Corporation to Announce First Quarter Fiscal 2021 Results on August 3, 2020
Keywords: Corporate, Investors, Corporate
July 01, 2020
McKesson Realigns Organizational Structure to Better Serve Customers and Patients While Optimizing Growth
Keywords: Corporate, Corporate
June 29, 2020
XPOVIO (selinexor), FDA Approved for Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL), Available at Biologics by McKesson
Keywords: Corporate, Corporate
June 05, 2020
Preliminary Research Involving Members of The US Oncology Network Finds Cancer Drug May Benefit Advanced COVID-19 Patients
Keywords: US Oncology Network, PSS-The US Oncology Network
June 04, 2020
McKesson Appoints Tom Rodgers to Executive Vice President & Chief Strategy and Business Development Officer
Keywords: Corporate, McKesson Ventures, Corporate
June 04, 2020
QINLOCK (Ripretinib), FDA Approved for Treatment of Gastrointestinal Stromal Tumors (GIST), Available at Biologics by McKesson
Keywords: Corporate, Corporate
June 02, 2020
RETEVMO (selpercatinib), FDA-Approved for Treatment of RET-driven Lung and Thyroid Cancers, Available at Biologics by McKesson
Keywords: Corporate, Corporate
May 28, 2020
Investigators from US Oncology Research and McKesson Present Data Highlighting Key Advances in Oncology Research at the 2020 American Society of Clinical Oncology Annual Meeting and Exposition
Keywords: US Oncology Network, PSS-The US Oncology Network
May 27, 2020
Pemazyre (pemigatinib) Available Exclusively at Biologics by McKesson
Keywords: Corporate, Corporate
May 20, 2020
McKesson Reports Fiscal 2020 Fourth-Quarter and Full-Year Results
Keywords: Corporate, Earnings, Investors, Corporate
May 12, 2020
Health Mart Pharmacies Launch COVID-19 Test Collection Sites
Keywords: PSS-Health Mart, Health Mart, Health Mart
May 11, 2020
TRODELVY (sacituzumab govitecan-hziy), FDA Approved for Treatment of Metastatic Triple-negative Breast Cancer, Available Only at Biologics by McKesson
Keywords: Corporate, Corporate
May 05, 2020
McKesson Appoints Lyn Fitzgerald as Vice President of Sales for McKesson Data, Evidence & Insights
Keywords: Corporate
April 29, 2020
McKesson Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
April 20, 2020
McKesson Corporation to Announce Fourth Quarter Fiscal 2020 Results on May 20, 2020
Keywords: Corporate, Earnings, Investors, Corporate
April 20, 2020
TUKYSA (tucatinib), FDA Approved for Treatment of Advanced Unresectable or Metastatic HER2 Positive Breast Cancer, Available at Biologics by McKesson
Keywords: Corporate, Corporate
March 31, 2020
The US Oncology Network names renowned cancer researcher Robert L. Coleman, MD, Chief Scientific Officer
Keywords: US Oncology Network
March 23, 2020
McKesson Announces Bansi Nagji to Step Down as Executive Vice President, Chief Strategy and Business Development Officer
Keywords: Corporate, Corporate
March 19, 2020
DOPTELET (avatrombopag) Now Available at Biologics by McKesson
Keywords: Corporate, Corporate
March 17, 2020
McKesson Updates Fiscal 2020 Guidance Following Completion of Change Healthcare Split-Off
Keywords: Corporate, Earnings, Investors, Corporate
March 12, 2020
McKesson Announces Final Results of Exchange Offer
Keywords: Corporate, Investors, Corporate
March 10, 2020
McKesson Completes Split-off of Its Interest in Change Healthcare
Keywords: Corporate, Investors, Corporate
March 10, 2020
McKesson Announces Preliminary Results of Exchange Offer
Keywords: Corporate, Investors, Corporate
March 05, 2020
McKesson Sets Final Exchange Ratio of 11.4086 for Exchange Offer
Keywords: Corporate, Investors, Corporate
March 03, 2020
Health Mart Independent Pharmacies Donate Their Dispensing Services to HHS to Support “Ending the HIV Epidemic” Initiative
Keywords: PSS-Health Mart, Health Mart, Health Mart
February 10, 2020
McKesson Launches Exchange Offer to Split-Off Its Interest in Change Healthcare
Keywords: Corporate, Corporate
February 04, 2020
McKesson Reports Fiscal 2020 Third-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
January 29, 2020
McKesson Declares Quarterly Dividend
Keywords: Corporate, Earnings, Investors, Corporate
January 27, 2020
McKesson Recognized as one of the “Best Places to Work for LGBTQ Equality” for Seventh Year in a Row
Keywords: Corporate, Corporate
January 17, 2020
AYVAKIT™ (avapritinib), FDA Approved for Treatment of PDGFRA Exon 18 Mutant GIST, Available at Biologics by McKesson
Keywords: Corporate, Corporate
January 16, 2020
McKesson Designated as 2020 Qualified Clinical Data Registry by CMS
Keywords: Corporate, Corporate
January 13, 2020
McKesson to Present at the 38th Annual J.P. Morgan Healthcare Conference: Will Provide Company Overview and Review Updated Financial Outlook
Keywords: Corporate, Corporate
January 03, 2020
McKesson Corporation to Announce Third Quarter Fiscal 2020 Results on February 4, 2020
Keywords: Corporate, Earnings, Investors, Corporate
December 18, 2019
McKesson Reaffirms Fiscal 2020 Guidance
Keywords: Corporate, Earnings, Investors, Corporate
December 12, 2019
McKesson Selected by Department of Veterans Affairs as Prime Pharmaceutical Provider
Keywords: Corporate, Corporate
December 12, 2019
Walgreens Boots Alliance and McKesson to Create German Wholesale Joint Venture
Keywords: Corporate, Corporate
December 10, 2019
McKesson to Host Sell-Side Analyst Meeting on December 18, 2019
Keywords: Corporate, Corporate
December 09, 2019
McKesson Appoints Nancy Flores as Executive Vice President, Chief Information and Chief Technology Officer
Keywords: Corporate, Corporate
December 09, 2019
McKesson Unveils Insight into Hospital Pharmacy Trends and What Industry Can Expect in 2020
Keywords: Corporate, Pharmacies, Healthcare Providers, Corporate
December 05, 2019
US Oncology Research Announces Schedule of Presentations at the 2019 American Society of Hematology Annual Meeting and Exposition
Keywords: US Oncology Network, Corporate, Providers, US Oncology, Healthcare Providers
October 30, 2019
McKesson Reports Fiscal 2020 Second-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
October 23, 2019
McKesson Declares Quarterly Dividend October 23, 2019
Keywords: Corporate, Earnings, Investors, Corporate
October 21, 2019
McKesson Hosts 2019 Onmark Summit for Community-Based Oncology Practices
Keywords: McKesson Specialty Health and US Oncology Network, Chronic Care Management, Providers, Electronic Health Records, Disease Management, Revenue Cycle Management
October 21, 2019
Distributors Reach Settlement With Ohio Counties in Opioids Case
Keywords: McKesson Specialty Health and US Oncology Network, McKesson Medical-Surgical, Corporate, McKesson U.S. Pharmaceutical, Providers, Consumers, Pharmacies, Manufacturers, Investors, Healthcare Providers, McKesson Medical-Surgical, Corporate
October 18, 2019
McKesson’s Board of Directors Appoints Maria Martinez as New Independent Director
Keywords: Corporate, Corporate
October 17, 2019
McKesson Leads Investment in Community Pharmacy Ownership
Keywords: Pharmaceutical Solutions & Services, McKesson U.S. Pharmaceutical, Health Mart, Pharmacies
October 15, 2019
McKesson and Aetion Collaborate to Advance Cancer Research with Real-World Data
Keywords: Corporate, Corporate
October 08, 2019
Fifteen Practices in The US Oncology Network Earn High-Quality Performance Ratings in the Oncology Care Model, Saving Medicare $35 Million
Keywords: US Oncology Network, Providers, Consumers, US Oncology, Healthcare Providers
October 04, 2019
McKesson Launches Strategic Planning Solution for Community-Based Oncology Customers
Keywords: Corporate, Corporate
October 03, 2019
McKesson and Augmedix Expand Collaboration to Enhance the Doctor-Patient Relationship
Keywords: Corporate, Corporate
September 30, 2019
McKesson Corporation to Announce Second Quarter Fiscal 2020 Results on October 30, 2019
Keywords: Corporate, Earnings, Investors, Corporate
September 25, 2019
AMP: Access for More Patients Transforms Patient Access to Specialty Medications
Keywords: McKesson Specialty Health and US Oncology Network, PSS-The US Oncology Network, Pharmaceutical Distribution, Manufacturers
September 11, 2019
McKesson and TrakCel Launch Innovative Collaboration to Support Commercialization of Cell and Gene Therapies
Keywords: McKesson Specialty Health and US Oncology Network, Biopharma, Pharmaceutical Distribution, Manufacturers
August 22, 2019
Blue Cross and Blue Shield of Minnesota and Minnesota Oncology Announce Five-Year Collaboration
Keywords: US Oncology Network, Providers, Consumers, US Oncology
August 08, 2019
McKesson Playing Pivotal Role in Phase II of Friends of Cancer Research Real-World Evidence Initiative
Keywords: Pharmaceutical Solutions & Services, McKesson U.S. Pharmaceutical, Providers, Electronic Health Records, Manufacturers
August 07, 2019
TURALIO (pexidartinib), FDA Approved Treatment of TGCT, Available at Biologics by McKesson
Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Solutions & Services, Providers, Consumers, Pharmaceutical Distribution, Manufacturers
August 01, 2019
NUBEQA (darolutamide), FDA Approved for Treatment of High-Risk Non-Metastatic Prostate Cancer, Available at Biologics by McKesson
Keywords: McKesson Specialty Health and US Oncology Network, PSS-The US Oncology Network, Consumers, Manufacturers
July 31, 2019
McKesson Reports Fiscal 2020 First-Quarter Results
Keywords: Corporate, Earnings, Investors, Corporate
July 25, 2019
McKesson Opens New Distribution Center in Seattle Area
Keywords: Corporate
July 17, 2019
McKesson Named One of the Best Places to Work for Disability Inclusion
Keywords: McKesson Ventures, Consumers, Investors, Corporate
July 09, 2019
Northern California Prostate Cancer Center Joins The US Oncology Network, Advancing Quality Care and Operational Efficiency
Keywords: US Oncology Network, Providers, US Oncology
July 08, 2019
XPOVIO (selinexor) Available for Order at Biologics by McKesson
Keywords: Corporate, Corporate
June 27, 2019
McKesson Issues Statement on Change Healthcare IPO
Keywords: Corporate, Corporate
June 25, 2019
McKesson ideaShare Empowers Independent Pharmacy
Keywords: Pharmaceutical Solutions & Services, McKesson U.S. Pharmaceutical, Health Mart, Pharmacies
June 17, 2019
McKesson’s Board of Directors Elects Dr. Ken Washington as New Independent Director
Keywords: Corporate, Investors, Corporate
June 10, 2019
Trumm Drug Named Health Mart Pharmacy of the Year
Keywords: Pharmaceutical Solutions & Services, McKesson U.S. Pharmaceutical, Health Mart, Pharmacies
May 30, 2019
Investigators from The US Oncology Network, US Oncology Research and McKesson Present More Than 60 Research Abstracts During the 2019 American Society of Clinical Oncology Annual Meeting
Keywords: US Oncology Network, PSS-The US Oncology Network, US Oncology
May 15, 2019
Community Pharmacists Unite, Learn, Grow at McKesson ideaShare
Keywords: Health Mart, Health Mart, Pharmacies
May 08, 2019
McKesson Reports Fiscal 2019 Fourth-Quarter and Full-Year Results
Keywords: Corporate, Earnings, Investors, Corporate
May 02, 2019
CIO Names McKesson’s Kathy McElligott to CIO Hall of Fame
Keywords: Corporate, Corporate
May 02, 2019
McKesson Reaches Settlement with State of West Virginia on Opioid Order Monitoring and Reporting
Keywords:
April 26, 2019
McKesson Appoints Tracy Faber to Top HR Role
Keywords: Corporate, Investors, Corporate
April 24, 2019
McKesson Declares Quarterly Dividend April 24, 2019
Keywords: Corporate, Investors, Corporate
April 15, 2019
Kirk Kaminsky to Lead McKesson’s U.S.-Based Pharmaceutical Business
Keywords: Corporate, Corporate
April 10, 2019
McKesson Corporation to Hold Fiscal 2019 Fourth Quarter Conference Call and Participate in the Bank of America Merrill Lynch Health Care Conference
Keywords: Corporate, Earnings, Investors, Corporate
April 02, 2019
Progress Towards a National Prescription Safety-Alert System: the Introduction of the ALERT Act
Keywords: Corporate
April 01, 2019
Brian Tyler Becomes McKesson’s New CEO
Keywords: Corporate, Investors, Corporate
March 28, 2019
McKesson Recognized as one of the “Best Places to Work for LGBTQ Equality” for Sixth Year in a Row
Keywords: Corporate, Corporate
March 26, 2019
iKnowMed Named Top-Performing Electronic Health Record by Black Book Research for Eighth Consecutive Year
Keywords: US Oncology Network, Providers, Consumers, Healthcare Providers
March 26, 2019
McKesson ideaShare Unites Independent Pharmacy
Keywords: Health Mart, Health Mart, Pharmacies
March 21, 2019
Biologics by McKesson Expands Specialty Pharmacy Capabilities to Serve Patients With Rare and Complex Conditions
Keywords: Providers, Consumers, Pharmaceutical Distribution, Manufacturers
March 05, 2019
McKesson Collaborates With Navigating Cancer to Offer Oncologists Enhanced Software Platform for Improved Patient Management in Value-Based Care
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records
January 31, 2019
McKesson Reports Fiscal 2019 Third-Quarter Results
Keywords: Earnings, Investors, Corporate
January 29, 2019
McKesson Joins World Cancer Day Efforts
Keywords: Providers, Consumers, Community Days, Electronic Health Records, US Oncology, Healthcare Providers, Corporate
January 28, 2019
Health Mart Welcomes President Nimesh Jhaveri
Keywords: Health Mart, Pharmacies
January 23, 2019
McKesson Designated as 2019 Qualified Clinical Data Registry by CMS
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records
January 07, 2019
McKesson Corporation Fiscal 2019 Third Quarter Conference Call Scheduled for January 31, 2019
Keywords: Earnings, Investors, Corporate
January 07, 2019
McKesson and Genpact Expand Their Relationship to Support McKesson’s Finance Operating Model Optimization
Keywords: Corporate
December 07, 2018
XOSPATA (gilteritinib) Available at Biologics by McKesson
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Healthcare Providers
December 06, 2018
Augmedix's EHR Documentation Platform Enters Innovative Pilot With Award-Winning iKnowMed Oncology EHR
Keywords: US Oncology Network, Providers, Consumers, Electronic Health Records, US Oncology, Healthcare Providers
December 03, 2018
McKesson Presents Innovative Solutions at ASHP Midyear Clinical Meeting
Keywords: McKesson U.S. Pharmaceutical, Pharmacies, Healthcare Providers
November 30, 2018
McKesson Announces New Global Headquarters in Las Colinas, Texas
Keywords: Corporate
November 30, 2018
US Oncology Research Announces Schedule of Presentations at the 2018 American Society of Hematology Annual Meeting and Exposition
Keywords: US Oncology Network, Providers, Consumers, US Oncology, Healthcare Providers
November 29, 2018
McKesson's 2019 Health System Pharmacy Trends
Keywords: McKesson U.S. Pharmaceutical, Pharmaceutical Distribution, Pharmacies, Healthcare Providers
November 27, 2018
Lynx Inventory System Now Customized for Retina Specialists
Keywords: McKesson Specialty Health and US Oncology Network, Chronic Care Management, Providers, Healthcare Providers
November 02, 2018
PANTHERx Specialty Pharmacy and RxCrossroads by McKesson Collaborate to Streamline the Channel for Precision Medicine Therapies
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Disease Management, Pharmaceutical Distribution, Manufacturers, Healthcare Providers
November 01, 2018
John Hammergren Announces Retirement; Brian Tyler to Become McKesson’s CEO and Edward Mueller to Chair Board
Keywords: Investors, Corporate
October 25, 2018
McKesson Reports Fiscal 2019 Second-Quarter Results
Keywords: Earnings, Investors, Corporate
October 23, 2018
RxBenefit Clarity Delivers Prescription Price Transparency to Providers on athenahealth’s Cloud-based EHR
Keywords: RelayHealth Pharmacy Solutions, Providers, Electronic Health Records, Pharmacies
October 22, 2018
McKesson Relaunches Life Sciences Business to Meet Changing Industry Needs
Keywords: McKesson Specialty Health and US Oncology Network, Electronic Health Records, Electronic Prescribing, Pharmaceutical Distribution, Manufacturers, Investors, Healthcare Providers
October 19, 2018
RelayHealth Pharmacy Solutions Strengthens Retail Pharmacies’ Efforts to Expand Clinical Services with Medical Billing Platform in Collaboration with STRAND Clinical Technologies
Keywords: RelayHealth Pharmacy Solutions, Pharmacies
October 11, 2018
McKesson Prepared to Help Customers, Employees and Communities in the Wake of Hurricane Michael
Keywords: Corporate
October 08, 2018
Impactful New Science and Advancements in Cancer Care Research Revealed and Discussed at the US Oncology Research 17th Annual Science Forum
Keywords: US Oncology Network, US Oncology
October 04, 2018
McKesson Corporation Fiscal 2019 Second Quarter Conference Call Scheduled for October 25, 2018
Keywords: Earnings, Investors, Corporate
October 04, 2018
The US Oncology Network Announces Top-Tier MIPS Results
Keywords: US Oncology Network, US Oncology
October 04, 2018
McKesson Sponsors Community Pharmacy Ownership Workshop
Keywords: Pharmacies, Corporate
October 01, 2018
Beyond the prescription: McKesson celebrates heroes in white coats
Keywords: McKesson U.S. Pharmaceutical, Pharmaceutical Distribution, Pharmacies
September 26, 2018
COPIKTRA (duvelisib) Available for Order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Disease Management, Healthcare Providers
September 26, 2018
McKesson Announces Renowned Leadership for Opioid-Focused Foundation
Keywords: Corporate
September 25, 2018
McKesson National Survey Reveals Most Americans Are Optimistic About New Technologies in Healthcare, yet Worry About Cancer Cost
Keywords: Providers, Consumers, Disease Management, US Oncology, Healthcare Providers, Corporate
September 25, 2018
McKesson Medical-Surgical and ILÚM Health Solutions Announce Distribution Alliance in Community Hospital Market
Keywords: Providers, Disease Management, Patient Safety, Investors, Healthcare Providers, McKesson Medical-Surgical
September 13, 2018
McKesson Board of Directors Elects Dominic Caruso as New Independent Director
Keywords: Corporate
September 12, 2018
Health Mart Launches National ‘Power Your Partnerships’ Series
Keywords: Health Mart, Health Mart, Pharmacies
August 23, 2018
McKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference
Keywords: Corporate
August 23, 2018
US Oncology Research Joins Agendia’s FLEX Big Data Initiative, Accelerating Diagnostic Discoveries in Breast Cancer and Enabling Precision Oncology
Keywords: US Oncology Network, Providers, US Oncology
August 15, 2018
Novocure and US Oncology Research Announce Collaboration on PANOVA-3 Trial for Patients with Advanced Pancreatic Cancer
Keywords: US Oncology Network, Providers, US Oncology
August 06, 2018
Progressive Care Integrates with Illinois Cancer Specialists to Join The US Oncology Network
Keywords: US Oncology Network, Providers, US Oncology
July 31, 2018
McKesson Appoints Brian Tyler as President and Chief Operating Officer
Keywords: Corporate
July 26, 2018
McKesson Reports Fiscal 2019 First-Quarter Results
Keywords: Earnings, Investors, Corporate
July 23, 2018
TIBSOVO (ivosidenib), an IDH1 Inhibitor Approved for Treatment of Relapsed/Refractory Acute Myeloid Leukemia with an IDH1 Mutation, Available for Order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Pharmaceutical Distribution
July 17, 2018
The US Oncology Network Promotes Leader in Value-Based Care Dr. Marcus Neubauer to Chief Medical Officer
Keywords: US Oncology Network, Consumers, US Oncology
July 09, 2018
Power of Community Pharmacies Showcased at McKesson ideaShare
Keywords: Health Mart, Health Mart, Pharmacies
July 09, 2018
The US Oncology Network Welcomes Breast Surgeon Dr. Loren Rourke to a New Role as Chief Surgical Officer
Keywords: US Oncology Network, Providers, US Oncology
July 05, 2018
McKesson Corporation Fiscal 2019 First Quarter Conference Call Scheduled for July 26, 2018
Keywords: Earnings, Investors, Corporate
June 29, 2018
Combination Therapy BRAFTOVI (encorafenib) and MEKTOVI (binimetinib) for the Treatment of BRAF-mutant Melanoma, Available for Order at Biologics, Inc.
Keywords: Pharmacies, Corporate
June 29, 2018
Bartle’s Pharmacy Receives McKesson’s Pharmacy of the Year Award
Keywords: Health Mart, Health Mart, Pharmacies
June 29, 2018
McKesson Debuts Drug Spend Savings Technology at HFMA
Keywords: Corporate
June 28, 2018
McKesson Reaffirms Fiscal 2019 Guidance and Provides Preliminary Guidance for the First Quarter
Keywords: Earnings, Corporate
June 26, 2018
McKesson Ventures Donates $10,000 to Meals on Wheels America on Behalf of Landmark Health
Keywords: McKesson Ventures
June 01, 2018
McKesson Completes Acquisition of Medical Specialties Distributors
Keywords: Corporate
May 30, 2018
Oncologists from The US Oncology Network and US Oncology Research to Present Data from More Than 40 Abstracts During the 54th Annual ASCO Meeting
Keywords: US Oncology Network, US Oncology
May 29, 2018
McKesson Corporation to Present at the Goldman Sachs 39th Annual Global Healthcare Conference and Host Investor Day
Keywords: Corporate
May 29, 2018
TAVALISSE (fostamatinib disodium hexahydrate) Approved by FDA, Available for Order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Pharmacies
May 24, 2018
McKesson Reports Fiscal 2018 Fourth-Quarter and Full-Year Results
Keywords: Earnings, Investors, Corporate
May 16, 2018
Real-World Evidence from McKesson Supports First-Ever FDA Approval for Metastatic Merkel Cell Carcinoma Drug
Keywords: US Oncology Network, Electronic Health Records, US Oncology, Manufacturers
May 07, 2018
McKesson ideaShare: The Independent’s Power to Perform
Keywords: McKesson U.S. Pharmaceutical, Pharmacies
May 07, 2018
Texas Oncology Receives 2018 PBMI Excellence Award for Care Management Strategies
Keywords: US Oncology Network
April 30, 2018
McKesson Board of Directors Elects Brad Lerman as New Independent Director
Keywords: Corporate
April 30, 2018
McKesson Corporation Fiscal 2018 Fourth Quarter Conference Call Scheduled for May 24, 2018
Keywords: Investors, Corporate
April 25, 2018
McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook and Provides Preliminary Fiscal 2019 Outlook
Keywords: Earnings, Investors, Corporate
April 20, 2018
McKesson Board of Directors Releases Findings and Recommendations of Independent Investigation
Keywords: Corporate
April 05, 2018
McKesson Launches Health Mart Atlas
Keywords: Corporate
April 05, 2018
McKesson Specialty Health Partners with CoverMyMeds to Deliver Keynote Address at eyeforpharma Philadelphia 2018
Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers
April 04, 2018
McKesson Specialty Health and CoverMyMeds Launch ExpressCoverage, an Integrated eServices Platform Designed to Improve the Patient Care Journey
Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers
March 29, 2018
McKesson Announces New Initiatives, Launches Foundation to Help Fight Nation’s Opioid Epidemic
Keywords: Investors, Corporate
March 12, 2018
Virginia Cancer Specialists and The US Oncology Network Welcome Breast Surgeon Dr. Hernan Vargas
Keywords: US Oncology Network, Providers, US Oncology
March 01, 2018
RelayHealth Pharmacy Solutions and CoverMyMeds Implement Industry's Most Accurate Real-Time Prescription Benefit Solution
Keywords: RelayHealth Pharmacy Solutions, Providers
February 27, 2018
James Drug Store Wins Team of the Year Award at Pharmacy Development Services Super-Conference
Keywords: Health Mart, Health Mart, Pharmacies
February 26, 2018
McKesson Specialty Health and Cryoport Collaborate to Bolster Logistics Services to Support Commercialization of Cell and Gene Therapies
Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers
February 22, 2018
McKesson Corporation Announces Pricing of Tender Offer
Keywords: Earnings, Investors, Corporate
February 22, 2018
McKesson Corporation Announces Early Tender Results
Keywords: Investors, Corporate
February 22, 2018
iKnowMed Ranked Number One Oncology Electronic Health Record by Black Book Research for Seventh Consecutive Year
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records
February 21, 2018
ERLEADA (apalutamide), the first FDA-approved treatment for non-metastatic, castration-resistant prostate cancer, available for order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Manufacturers
February 07, 2018
McKesson Pharmacy Systems and Creative Pharmacist Collaborate to Enhance Clinical Programs for Community Pharmacy
Keywords: Pharmacies, McKesson Pharmacy Systems
February 01, 2018
McKesson Reports Fiscal 2018 Third-Quarter Results
Keywords: Earnings, Corporate
January 26, 2018
McKesson Specialty Health Designated as 2018 Qualified Clinical Data Registry by CMS
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records
January 25, 2018
Biologics, Inc. Joins Medimpact Direct Specialty Program’s Specialty Pharmacy Network
Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers
January 18, 2018
Consultants in Medical Oncology and Hematology Joins The US Oncology Network, Enhancing Its Ability to Deliver High-Quality Care throughout the Greater Philadelphia Area
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
January 16, 2018
McKesson Ventures Donates $10,000 to Alzheimer’s Association
Keywords: McKesson Ventures, Corporate
January 05, 2018
iKnowMed EHR and iKnowMed Generation 2 EHR Receive 2015 ONC-ACB Certification
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records
January 04, 2018
McKesson Corporation Fiscal 2018 Third Quarter Conference Call Scheduled for February 1, 2018
Keywords: Investors, Corporate
January 03, 2018
McKesson Completes Acquisition of RxCrossroads
Keywords: Corporate
December 21, 2017
BenchmarkPortal Certifies McKesson Specialty Health’s Third Party Logistics Service Center as Center of Excellence
Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers
December 19, 2017
McKesson Corporation to Present at the 36th Annual J.P. Morgan Healthcare Conference
Keywords: Corporate
December 18, 2017
McKesson Announces Departure of James Beer, EVP and CFO; Appoints Internal Successor, Britt Vitalone; Reaffirms Fiscal 2018 Outlook
Keywords: Corporate
December 04, 2017
McKesson Specialty Health and US Oncology Research Announce Schedule of Presentations at the 2017 American Society of Hematology Annual Meeting and Exposition
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
December 04, 2017
McKesson RxO Team Identifies Five Health System Pharmacy Trends to Watch in 2018
Keywords: McKesson U.S. Pharmaceutical
December 01, 2017
McKesson to Showcase Clinical Expertise and Technology Solutions at ASHP Midyear Clinical Meeting 2017
Keywords: McKesson U.S. Pharmaceutical, Pharmacies
November 28, 2017
Virginia Cancer Specialists and The US Oncology Network Welcome Dr. Stephanie Akbari
Keywords: US Oncology Network, US Oncology, Healthcare Providers
November 09, 2017
Human Rights Campaign Honors McKesson as a Best Place to Work for Fifth Consecutive Year
Keywords: Corporate
November 06, 2017
McKesson Strengthens Its Portfolio of Manufacturer Solutions With the Acquisition of RxCrossroads
Keywords: Pharmaceutical Distribution, Investors, Corporate
November 03, 2017
Frederick Oncology & Hematology Associates Joins Maryland Oncology Hematology and The US Oncology Network
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
November 02, 2017
US Oncology Research Annual Science Forum Focuses on Advances in Clinical Research, Enabling Promising New Treatments for Patients in the Community Setting
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
November 01, 2017
CALQUENCE® (acalabrutinib) Approved for Previously-Treated Mantle Cell Lymphoma, Available for Order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers
October 31, 2017
McKesson Recommends Quick Federal Action on Key Opioid Solution Ideas
Keywords: Providers, Pharmaceutical Distribution, Pharmacies, Manufacturers, Healthcare Providers, Corporate
October 30, 2017
McKesson Signs Agreement with NRG to Install Solar Arrays at McKesson Facility
Keywords: Corporate
October 26, 2017
McKesson Reports Fiscal 2018 Second-Quarter Results
Keywords: Earnings, Investors, Corporate
October 23, 2017
Health Mart and APCI Celebrate Pharmacists on Florida Independent Pharmacy Day
Keywords: McKesson U.S. Pharmaceutical
October 23, 2017
McKesson Supports Declaring Opioid Epidemic a National Emergency
Keywords: Corporate
October 17, 2017
McKesson Corporation to Present at the 26th Annual Credit Suisse Healthcare Conference
Keywords: Corporate
October 17, 2017
McKesson Partners with Lyft to Support California Wildfire Victims
Keywords: Corporate
October 17, 2017
Health Mart Showcases Solutions for Clinical and Financial Performance at NCPA
Keywords: Health Mart, Health Mart, Pharmacies
October 16, 2017
McKesson RxOwnership Expands Support of Independent Pharmacy Ownership
Keywords: McKesson U.S. Pharmaceutical, Pharmacies
October 13, 2017
McKesson Commits $100,000 to the American Red Cross to Support California Wildfire Victims
Keywords: Corporate
October 11, 2017
VERZENIO (abemaciclib) Approved for Treatment of Metastatic Breast Cancer, Available for Order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Manufacturers
October 05, 2017
McKesson Corporation Fiscal 2018 Second Quarter Conference Call Scheduled for October 26, 2017
Keywords: Earnings, Investors, Corporate
October 02, 2017
Employee Volunteers Create 15,000 Care Packages for Cancer Patients
Keywords: Consumers, Community Days, Corporate
September 27, 2017
McKesson Ventures Expands Investment Team
Keywords: McKesson Ventures, Corporate
September 25, 2017
Health Mart Kicks-Off New ‘Revenue Remedies’ Town Hall Series
Keywords: Health Mart, Health Mart, Pharmacies
September 19, 2017
Southern Cancer Center is Global Leader in Kidney Cancer Clinical Trial
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
September 14, 2017
McKesson Increases Hurricane Relief Commitment to $600,000
Keywords:
September 12, 2017
US Oncology Research Plays an Important Role in the Clinical Development for NERLYNX™ (Neratinib) Tablets
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology, Pharmaceutical Distribution, Manufacturers
September 08, 2017
Hurricane Irma: McKesson Prepares to Support Healthcare Providers, Pharmacies and First Responders
Keywords: Corporate
August 31, 2017
McKesson Commits More than $300,000 in Relief Support for Hurricane Harvey
Keywords: Consumers, Investors, Corporate
August 22, 2017
McKesson Corporation to Present at the Morgan Stanley Global Healthcare Conference
Keywords: Investors, Corporate
August 22, 2017
BESPONSA (inotuzumab ozogamicin) Approved for Treatment of Adult Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia, available for order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Manufacturers
August 03, 2017
Allscripts to Acquire McKesson’s Enterprise Information Solutions Business
Keywords: Providers, Electronic Health Records, Investors, Corporate
August 01, 2017
US Oncology Research and Epizyme Establish Collaboration to Identify Non-Hodgkin Lymphoma Patients with EZH2 Mutations
Keywords: US Oncology Network, Providers, US Oncology
July 28, 2017
McKesson Announces Final Voting Results from 2017 Annual Meeting of Stockholders
Keywords: Investors, Corporate
July 27, 2017
McKesson Reports Fiscal 2018 First-Quarter Results
Keywords: Earnings, Investors, Corporate
July 26, 2017
McKesson Declares Quarterly Dividend July 26, 2017
Keywords: Earnings, Investors, Corporate
July 26, 2017
McKesson Announces Preliminary Voting Results from 2017 Annual Meeting of Stockholders
Keywords: Investors, Corporate
July 21, 2017
NERLYNX (neratinib) Tablets Approved for HER2+ Breast Cancer in the Extended Adjuvant Setting
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Manufacturers
July 13, 2017
McKesson ideaShare: Shaping the Independent’s Power to Drive Performance and Profitability
Keywords: McKesson U.S. Pharmaceutical, Pharmaceutical Distribution, Pharmacies
July 12, 2017
McKesson Corporation Fiscal 2018 First Quarter Conference Call Scheduled for July 27, 2017
Keywords: Earnings, Investors, Corporate
July 10, 2017
McKesson Pharmacy Systems Unveils Key Enhancements for Its Pharmacy Management Product Lines
Keywords: Pharmacies, McKesson Pharmacy Systems
July 06, 2017
Mac Prescription Shop Health Mart Receives McKesson’s 2017 Pharmacy of the Year Award
Keywords: Health Mart, Health Mart, Pharmacies
July 05, 2017
McKesson Specialty Health Completes Acquisition of intraFUSION
Keywords: McKesson Specialty Health and US Oncology Network, Providers, M&A
June 29, 2017
Biologics, Inc. Earns Prestigious URAC Accreditation for Specialty Pharmacy
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Pharmacies, Manufacturers, Investors, Healthcare Providers
June 28, 2017
McKesson Reaffirms Fiscal 2018 Guidance
Keywords: Earnings, Investors, Corporate
June 23, 2017
The US Oncology Network Hosts Second Annual Boot Camp Focusing on New Value-Based Care and Payment Models
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
June 22, 2017
McKesson Specialty Health Expands Provider Offerings with Acquisition of intraFUSION
Keywords: McKesson Specialty Health and US Oncology Network, Providers, M&A
June 21, 2017
McKesson Corporation to Webcast Investor Day
Keywords: Investors, Corporate
June 14, 2017
McKesson Specialty Health and The US Oncology Network Expand Agreement with The National Comprehensive Cancer Network, Adding New Disease States to Value Pathways
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
June 13, 2017
Arizona Oncology Opens State-of-the-Art Cancer Treatment Center at ASU Research Park
Keywords: US Oncology Network, Providers, Consumers, US Oncology
June 08, 2017
Virginia Cancer Specialists Opens New Research Facility for Phase I Clinical Trials, Leading the Region in Advanced Cancer Research
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
June 01, 2017
McKesson Specialty Health Approved as Qualified Clinical Data Registry by CMS
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records
May 31, 2017
Community Oncologists from The US Oncology Network and US Oncology Research Share Meaningful Research and Visionary Thinking During American Society of Clinical Oncology Annual Meeting
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
May 25, 2017
McKesson Corporation to Present at the Goldman Sachs 38th Annual Global Healthcare Conference
Keywords: Corporate
May 24, 2017
McKesson Declares Quarterly Dividend May 24, 2017
Keywords: Earnings, Investors, Corporate
May 24, 2017
Biologics’ Patient Access Services Team Procures more than $44 Million in Co-pay Assistance for Cancer Patients in 2016
Keywords: McKesson Specialty Health and US Oncology Network, Consumers, Pharmaceutical Distribution, Pharmacies
May 22, 2017
IMFINZI (durvalumab) Approved for Previously Treated Patients with Advanced Bladder Cancer, available immediately at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Pharmacies, Manufacturers
May 18, 2017
McKesson Reports Fiscal 2017 Fourth-Quarter and Full-Year Results
Keywords: Earnings, Investors, Corporate
May 12, 2017
McKesson Specialty Health Selected by TESARO to provide ZEJULA (niraparib), Approved for the Treatment of Recurrent Ovarian Cancer
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology, Pharmaceutical Distribution, Pharmacies, Manufacturers
May 11, 2017
ALUNBRIG (brigatinib) Approved for the Treatment of ALK+ Metastatic Non-Small Cell Lung Cancer, Available for Order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Manufacturers
May 03, 2017
RYDAPT (midostaurin) Approved for the Treatment of FLT3-Mutated Acute Myeloid Leukemia, available for order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Manufacturers
April 27, 2017
Thought Leaders from McKesson Specialty Health and The US Oncology Network Are Key Presenters at the 2017 Community Oncology Conference
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
April 25, 2017
US Oncology Research Enrolls 2,900 Patients in Leading-Edge Clinical Trials in Twelve Months
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
April 24, 2017
Biologics, Inc. Selected by TESARO as a Specialty Pharmacy Provider for ZEJULA (niraparib), Approved for the Treatment of Recurrent Ovarian Cancer
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Pharmaceutical Distribution
April 20, 2017
McKesson Corporation Fiscal 2017 Fourth Quarter Conference Call Scheduled for May 18, 2017
Keywords: Earnings, Investors, Corporate
April 20, 2017
McKesson Response to Arkansas Department of Correction’s Planned Executions
Keywords: Corporate
April 11, 2017
McKesson Presents New Approaches to Patient-Centric Behavioral Coaching at CBI Conference
Keywords: McKesson Specialty Health and US Oncology Network, Pharmaceutical Distribution, Manufacturers
April 03, 2017
McKesson Completes Acquisition of CoverMyMeds
Keywords: Pharmaceutical Distribution, Pharmacies, Corporate
March 30, 2017
McKesson ideaShare: Shaping the Independent’s Power to Perform
Keywords:
March 29, 2017
BAVENCIO (avelumab) Approved for the Treatment of Metastatic Merkel Cell Carcinoma, Available for Order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Pharmaceutical Distribution
March 17, 2017
KISQALI (ribociclib) Approved for the Treatment of HR+/HER2- Advanced Breast Cancer, available for order at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Pharmaceutical Distribution
March 02, 2017
McKesson and Change Healthcare Complete the Creation of New Healthcare Information Technology Company
Keywords: Corporate
March 02, 2017
McKesson Provides Financial Update to Reflect Creation of a New Healthcare Information Technology Company
Keywords: Earnings, Corporate
March 01, 2017
Medical Oncology Hematology Consultants Joins The US Oncology Network
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
March 01, 2017
XERMELO (telotristat ethyl) Approved for the Treatment of Carcinoid Syndrome, Available for Order Immediately at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Pharmaceutical Distribution
February 28, 2017
Black Book Research Recognizes iKnowMed as the Number One Ranked Oncology Electronic Health Record for Sixth Consecutive Year
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records
February 02, 2017
McKesson Specialty Health and The US Oncology Network to Showcase Value-Based Care Expertise During Cancer Center Business Summit
Keywords: McKesson Specialty Health and US Oncology Network, Providers
February 01, 2017
Southern Cancer Center Joins The US Oncology Network
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
January 25, 2017
McKesson Reports Fiscal 2017 Third-Quarter Results
Keywords: Earnings, Investors, Corporate
January 25, 2017
McKesson Declares Quarterly Dividend January 25, 2017
Keywords: Earnings, Investors, Corporate
January 17, 2017
McKesson Finalizes Settlement with U.S. Department of Justice and U.S. Drug Enforcement Administration to Resolve Past Claims
Keywords: Corporate
January 11, 2017
McKesson Specialty Health and The US Oncology Network Invited to Participate in the Final White House “Making Health Care Better” Series Focused on Community Oncology
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
January 05, 2017
McKesson and Change Healthcare Announce New Company Will Be Named Change Healthcare
Keywords:
January 04, 2017
McKesson Corporation Fiscal 2017 Third Quarter Conference Call Scheduled for January 25, 2017
Keywords:
December 28, 2016
McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada
Keywords: Corporate
December 20, 2016
McKesson Corporation to Present at 35th Annual J.P. Morgan Healthcare Conference
Keywords: Investors, Corporate
December 20, 2016
RUBRACA (rucaparib) Approved for the Treatment of Advanced Ovarian Cancer, Available Immediately at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Manufacturers
December 14, 2016
McKesson Receives Regulatory Approval for Rexall Health Acquisition
Keywords: Pharmaceutical Distribution, Pharmacies, Corporate
December 13, 2016
McKesson Specialty Health Expands Operations with New Office in Downtown Evansville, Indiana
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Revenue Cycle Management
December 08, 2016
US Oncology Research Annual Science Forum Focuses on Delivering the Latest Research Opportunities to Patients in the Community Setting
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
December 05, 2016
Human Rights Campaign Honors McKesson Corporation as Best Place to Work for LGBT Employees for Fourth Year in a Row
Keywords:
December 05, 2016
McKesson Pharmacy Optimization® Team Identifies Five Health System Pharmacy Trends to Watch in 2017
Keywords: McKesson U.S. Pharmaceutical, Pharmaceutical Distribution, Nurses
December 02, 2016
McKesson Introduces Central Fill as a Service™
Keywords: Chronic Care Management, McKesson U.S. Pharmaceutical, Disease Management, Pharmaceutical Distribution, Pharmacies, McKesson Pharmacy Systems
December 02, 2016
McKesson to Spotlight Solutions at ASHP Midyear Clinical Meeting 2016
Keywords: McKesson Ventures, McKesson U.S. Pharmaceutical, Pharmacies
December 01, 2016
Blood & Cancer Center Joins Florida Cancer Affiliates
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
November 30, 2016
US Oncology Research Announces Schedule of Presentations at the 2016 American Society of Hematology Annual Meeting and Exposition
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
November 15, 2016
Rocky Mountain Cancer Centers First In Region to Offer Newly Approved Gallium DOTATATE PET/CT for Neuroendocrine Tumors
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
November 14, 2016
McKesson Pharmacy Systems Unveils EnterpriseRx® 7.0
Keywords: Patient Safety, Pharmacies, Healthcare Providers, McKesson Pharmacy Systems
November 10, 2016
McKesson Specialty Health Launches Its Successful In-Office Dispensing Solution to Rheumatology and Gastroenterology Providers
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Pharmaceutical Distribution
November 07, 2016
McKesson Specialty Health Hosts 2016 Onmark Fall Leadership Summit For Community-Based Oncology Practices
Keywords: McKesson Specialty Health and US Oncology Network, Providers
November 03, 2016
BenchmarkPortal Certifies McKesson Specialty Health’s Reimbursement, Access & Safety Services Solution Center as Center of Excellence
Keywords: McKesson Specialty Health and US Oncology Network, Consumers, Patient Safety, Manufacturers
November 02, 2016
Lancet Oncology Multi-Part Study on Oncology Drug Safety in the 21st Century Reveals the Need for New Approaches to Biosimilar and Generic Oncology Drugs
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology, Manufacturers
November 01, 2016
OHC Joins The US Oncology Network, Gaining Resources to Advance Quality Care and Operational Efficiency
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
October 27, 2016
McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook
Keywords: Earnings, Investors, Corporate
October 27, 2016
McKesson Declares Quarterly Dividend October 27, 2016
Keywords: Earnings, Investors, Corporate
October 26, 2016
Varian and McKesson Specialty Health Announce Strategic Agreement for Advanced Radiotherapy Equipment and Software
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records, US Oncology
October 24, 2016
McKesson Releases Fiscal 2016 Corporate Social Responsibility Report
Keywords: Consumers, Investors, Corporate
October 20, 2016
McKesson Corporation to Present at the 25th Annual Credit Suisse Healthcare Conference
Keywords: Corporate
October 18, 2016
Health Mart Showcases New Tools to Drive Better Patient Outcomes and Business Growth at NCPA
Keywords: Health Mart, Health Mart, Pharmacies
October 18, 2016
Compass Oncology Breaks Ground on Multi-Disciplinary Cancer Center
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
October 06, 2016
McKesson Corporation Fiscal 2017 Second Quarter Conference Call Scheduled for October 27, 2016
Keywords: Earnings, Investors, Corporate
October 05, 2016
McKesson RxOwnership Supports Future of Independent Pharmacy Ownership at NCPA Annual Convention
Keywords: McKesson U.S. Pharmaceutical, Pharmacies
October 05, 2016
CABOMETYXTM (cabozantinib) Tablets Approved for Advanced Renal Cell Carcinoma, available at Biologics, Inc.
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, Pharmaceutical Distribution, Manufacturers
October 04, 2016
The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
September 30, 2016
McKesson Salutes Important Role Pharmacists Play in Improving Patient Health During American Pharmacists Month
Keywords: Health Mart, Providers, Consumers, Health Mart, Pharmacies
September 29, 2016
Clear Value Plus Reaches Milestone 100,000th Clinical Decision Recorded
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Electronic Health Records
September 26, 2016
Health Mart® Kicks-Off New Town Hall Series: Resolve to Evolve to Help Pharmacies Improve their Clinical, Financial, and Operational Performance for Profitability
Keywords: Health Mart, Consumers, Health Mart, Pharmacies, Healthcare Providers
September 23, 2016
McKesson Pharmacy Systems Launches Pharmaserv 7.5
Keywords: Chronic Care Management, Disease Management, Patient Safety, Pharmacies, McKesson Pharmacy Systems
September 22, 2016
Arizona Oncology Implements Advanced Cervical Imaging Technology to Assist With the Early Detection of Cervical Cancer
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
September 20, 2016
18,000 McKesson Employees Gather to Raise Awareness, Give Back to Cancer Patients in Need
Keywords: Community Days, Corporate
September 15, 2016
Health Mart® Ranks Highest in Customer Satisfaction in J.D. Power 2016 U.S. Pharmacy Study
Keywords: Health Mart, Health Mart, Pharmacies
September 14, 2016
McKesson a Finalist for PM360 Trailblazer Awards 2016
Keywords: McKesson Specialty Health and US Oncology Network, McKesson U.S. Pharmaceutical, Consumers, Patient Safety, Manufacturers
September 12, 2016
Arizona Oncology Adds Four Gynecologic Oncologists, Expanding World-Class Gynecologic Cancer Services Throughout the Region
Keywords: McKesson Specialty Health and US Oncology Network, Providers, Consumers, US Oncology
September 06, 2016
Woodlands Medical Specialists Joins The US Oncology Network
Keywords: US Oncology Network, Providers, US Oncology
August 25, 2016
New Study Shows Lumpectomy With Radiation Therapy to Treat Breast Cancer in a Community Setting Results in Higher Than Average Patient Survival Rates
Keywords: McKesson Specialty Health and US Oncology Network
August 23, 2016
McKesson Corporation to Present at Morgan Stanley Global Healthcare Conference
Keywords: Investors, Corporate
August 09, 2016
Missouri Cancer Associates Adds New Physician, Enhancing Access to Quality Care
Keywords: US Oncology Network
July 27, 2016
McKesson Reports Fiscal 2017 First-Quarter Results
Keywords: Earnings, Investors, Corporate
July 26, 2016
McKesson Declares Quarterly Dividend July 26, 2016
Keywords: Investors, Corporate
July 22, 2016
Arizona Oncology Breaks Ground for State-of-the-art Treatment Center in the East Valley
Keywords: US Oncology Network, Providers, US Oncology
July 21, 2016
SpaceOAR hydrogel is Now Available for Prostate Cancer Patients Being Treated at Arizona Oncology
Keywords: US Oncology Network, Providers, US Oncology
July 14, 2016
Virginia Cancer Specialists First in the World to Enroll Patient in Cutting-Edge Lung Cancer Clinical Trial
Keywords: US Oncology Network, Providers, US Oncology
July 12, 2016
Virginia Cancer Specialists Receives Clinical Trials Research Award from Conquer Cancer Foundation
Keywords: US Oncology Network, Providers, US Oncology
July 07, 2016
McKesson Corporation Fiscal 2017 First Quarter Conference Call Scheduled for July 27, 2016
Keywords: Earnings, Investors, Corporate
July 05, 2016
Anthem Blue Cross of California and Valley Radiotherapy Associates Implement New Rates for Breast Cancer Patients
Keywords: McKesson Specialty Health and US Oncology Network, Providers
June 30, 2016
The US Oncology Network Announces Affiliated Practices Chosen To Participate In Oncology Care Model (OCM)
Keywords: US Oncology Network, US Oncology
June 29, 2016
McKesson Updates Fiscal 2017 Guidance
Keywords: Earnings, Corporate
June 28, 2016
McKesson to Explore Strategic Alternatives for Enterprise Information Solutions
Keywords: Corporate
June 27, 2016
Rex Pharmacy, a Health Mart Pharmacy, Receives McKesson’s 2016 Pharmacy of the Year Award
Keywords: Health Mart, Providers, Consumers, Health Mart, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers
June 27, 2016
McKesson Shares Ideas with Independent Pharmacies to Deliver Better Patient Outcomes and Grow Their Businesses
Keywords: Providers, Consumers, Health Mart, Pharmacies, Nurses, Manufacturers, Investors, Healthcare Providers, Corporate
June 22, 2016
McKesson Corporation to Webcast Investor Day
Keywords: Corporate
June 20, 2016
McKesson Specialty Health Launches Optimization Toolkit for Oncology In-Office Dispensing Program
Keywords: McKesson Specialty Health and US Oncology Network, Providers
June 08, 2016
The US Oncology Network Holds Intensive Boot Camp to Prepare Oncology Practices for July Launch of Oncology Care Model (OCM)
Keywords: US Oncology Network, Providers, US Oncology
June 02, 2016
Virginia Cancer Specialists Receives 2016 Governor’s Volunteerism and Community Service Award for Small Business Category
Keywords: US Oncology Network, Providers
June 01, 2016
ASCO Annual Meeting: The US Oncology Network and US Oncology Research Affiliated Investigators to Showcase Clinical Study Results From 30 Abstracts
Keywords: US Oncology Network, Providers, US Oncology
May 25, 2016
McKesson Driving Success of Independent Pharmacy
Keywords: Health Mart, Health Mart, Pharmaceutical Distribution, Pharmacies
May 25, 2016
McKesson Declares Quarterly Dividend May 25, 2016
Keywords: Investors, Corporate
May 16, 2016
McKesson and Walmart Announce Sourcing Agreement for Generic Pharmaceuticals
Keywords: Corporate
May 09, 2016
Texas Center for Proton Therapy Treats First Patient with Isocentric Cone Beam CT and Pencil Beam Scanning
Keywords: US Oncology Network, Providers, US Oncology
May 05, 2016
McKesson Specialty Health Solution Helps Community-Based Cancer Care Providers Participate in the Oncology Care Model
Keywords: McKesson Specialty Health and US Oncology Network, Providers, US Oncology
May 04, 2016
McKesson Reports Fiscal 2016 Fourth-Quarter and Full-Year Results
Keywords: Earnings, Investors, Corporate
May 03, 2016
McKesson Recognized for Technology Innovation on InformationWeek’s 2016 “Elite 100” List
Keywords: Pharmaceutical Distribution, Manufacturers, Corporate
April 28, 2016
McKesson Specialty Health’s iKnowMed℠ Earns Highest KLAS Ratings in Key Performance Categories
Keywords: McKesson Specialty Health and US Oncology Network, Electronic Health Records
April 25, 2016
McKesson to Deliver Keynote Address at eyeforpharma Philadelphia 2016
Keywords: Pharmacies
April 20, 2016
McKesson Corporation to Present at the Bank of America Merrill Lynch 2016 Health Care Conference
Keywords: Investors, Corporate

top